lactic acid has been researched along with oligonucleotides in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (8.33) | 18.2507 |
| 2000's | 13 (54.17) | 29.6817 |
| 2010's | 9 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ando, H; Asakawa, N; Ishida, M; Kato, T; Yamakawa, I | 1 |
| Allémann, E; Benimetskaya, L; Berton, M; Gurny, R; Stein, CA | 1 |
| Allémann, E; Berton, M; Gurny, R; Stein, CA; Trono, D; Turelli, P | 1 |
| Alphandary, H; Appel, M; De Rosa, G; Fattal, E; La Rotonda, MI; Quaglia, F | 1 |
| Currier, BL; Lu, L; Windebank, AJ; Yaszemski, MJ; Zhu, X | 1 |
| Gill, JS; Lu, L; Moore, MJ; Windebank, AJ; Yaszemski, MJ; Zhu, X | 1 |
| Besnard, M; De Rosa, G; Fattal, E; La Rotonda, M; Quaglia, F | 1 |
| Adamis, AP; Carrasquillo, KG; Gragoudas, ES; Miller, JW; Ricker, JA; Rigas, IK | 1 |
| De Rosa, G; Miro, A; Quaglia, F; Ungaro, F | 1 |
| Farokhzad, OC; Jon, S; Khademhosseini, A; Langer, R; Lavan, DA; Tran, TN | 1 |
| Carnuccio, R; De Rosa, G; De Stefano, D; La Rotonda, MI; Maiuri, MC; Quaglia, F; Ungaro, F | 1 |
| Hu, Y; Sun, WQ; Wang, HF; Wei, WN; Xie, CS; Yao, JX; Zheng, JE | 1 |
| Hartmann, G | 1 |
| Choleris, E; Langer, R; Little, SR; Mong, JA; Pfaff, DW; Puram, SV | 1 |
| Basta, S; Busch, DH; Fischer, S; Gander, B; Groettrup, M; Mueller, M; Schlosser, E | 1 |
| Chin, JY; Fields, RJ; Glazer, PM; McNeer, NA; Saltzman, WM; Schleifman, EB | 1 |
| Bando, Y; Kawashima, Y; Morishita, R; Samura, S; Tahara, K; Tsuji, K; Tsujimoto, H; Tsukada, Y; Yamamoto, H | 1 |
| Cordido, F; Helmling, S; Klussmann, S; Sangiao-Alvarellos, S; Vázquez, MJ | 1 |
| Arima, Y; Iwata, H; Matsui, T; Takemoto, N | 1 |
| Beeks, CG; Hinchman, AN; Klimecki, WT; Li, H; Malm, SW; Zhao, F | 1 |
| Hu, F; Liang, G; Sun, B; Tian, T; Xiao, Z; Zhu, Y | 1 |
| Ambrosini, V; Caputo, P; Costabile, G; d'Angelo, I; d'Emmanuele di Villa Bianca, R; Donnarumma, G; Miro, A; Perfetto, B; Quaglia, F; Sorrentino, R; Ungaro, F | 1 |
| Guo, RM; Jiao, J; Zhang, Y; Zhu, S; Zou, MH; Zou, Q | 1 |
| Chitnis, NB; Gupta, SK; Kushwaha, H; Nalage, VHH; Salvi, D; Sharma, A; Shukla, P; Srivastava, SK | 1 |
24 other study(ies) available for lactic acid and oligonucleotides
| Article | Year |
|---|---|
Release behavior of poly(lactic acid-co-glycolic acid) implants containing phosphorothioate oligodeoxynucleotide.
Topics: Animals; Biocompatible Materials; Cattle; Drug Implants; Lactic Acid; Molecular Weight; Oligonucleotides; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Prostheses and Implants; Thionucleotides; Vitreous Body | 1997 |
Uptake of oligonucleotide-loaded nanoparticles in prostatic cancer cells and their intracellular localization.
Topics: Humans; Lactic Acid; Male; Oligonucleotides; Polyesters; Polymers; Prostatic Neoplasms; Thionucleotides; Tumor Cells, Cultured | 1999 |
Inhibition of HIV-1 in cell culture by oligonucleotide-loaded nanoparticles.
Topics: Cell Survival; Cells, Cultured; Drug Compounding; Excipients; HeLa Cells; HIV Reverse Transcriptase; HIV-1; Humans; Indicators and Reagents; Lactic Acid; Lymphocytes; Microspheres; Oligonucleotides; Oligonucleotides, Antisense; Polyesters; Polymers; Reverse Transcriptase Inhibitors; Transfection; Virus Replication | 2001 |
Poly(lactide-co-glycolide) microspheres for the controlled release of oligonucleotide/polyethylenimine complexes.
Topics: Biocompatible Materials; Cell Membrane Permeability; Cell Survival; Delayed-Action Preparations; Drug Compounding; Drug Delivery Systems; HeLa Cells; Humans; Lactic Acid; Microscopy, Confocal; Microscopy, Electron, Scanning; Microspheres; Oligonucleotides; Particle Size; Polyethyleneimine; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Solubility | 2002 |
Controlled release of NFkappaB decoy oligonucleotides from biodegradable polymer microparticles.
Topics: Biocompatible Materials; Drug Delivery Systems; Hydrogen-Ion Concentration; Kinetics; Lactic Acid; Magnetic Resonance Spectroscopy; Microscopy, Electron, Scanning; NF-kappa B; Oligonucleotides; Oligonucleotides, Antisense; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Time Factors | 2002 |
Effects of NFkappaB decoy oligonucleotides released from biodegradable polymer microparticles on a glioblastoma cell line.
Topics: Active Transport, Cell Nucleus; Biocompatible Materials; Biodegradation, Environmental; Blotting, Western; Cell Division; Cell Line; Cells, Cultured; Cyclin D1; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinases; Glioblastoma; Humans; Immunoblotting; Kinetics; Lactic Acid; Neuroglia; NF-kappa B; Oligonucleotides; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Proto-Oncogene Proteins; Time Factors; Tumor Cells, Cultured | 2002 |
Biodegradable microparticles for the controlled delivery of oligonucleotides.
Topics: Delayed-Action Preparations; Drug Carriers; Drug Compounding; HeLa Cells; Humans; Lactic Acid; Microscopy, Confocal; Microspheres; Oligonucleotides; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers | 2002 |
Controlled delivery of the anti-VEGF aptamer EYE001 with poly(lactic-co-glycolic)acid microspheres.
Topics: Animals; Biocompatible Materials; Cell Division; Cells, Cultured; Circular Dichroism; Drug Carriers; Drug Delivery Systems; Endothelium, Vascular; Humans; Lactic Acid; Microspheres; Oligonucleotides; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rabbits; Sclera; Umbilical Veins | 2003 |
Spectrophotometric determination of polyethylenimine in the presence of an oligonucleotide for the characterization of controlled release formulations.
Topics: Algorithms; Copper; Delayed-Action Preparations; Excipients; Hydrogen-Ion Concentration; Indicators and Reagents; Lactic Acid; Microspheres; Oligonucleotides; Polyethyleneimine; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Reference Standards; Reproducibility of Results; Sodium Hydroxide; Spectrophotometry, Ultraviolet | 2003 |
Nanoparticle-aptamer bioconjugates: a new approach for targeting prostate cancer cells.
Topics: Antigens, Surface; Cell Line, Tumor; Drug Delivery Systems; Glutamate Carboxypeptidase II; Humans; Lactic Acid; Male; Oligonucleotides; Polyesters; Polyethylene Glycols; Polymers; Prostatic Neoplasms | 2004 |
Enhanced intracellular uptake and inhibition of NF-kappaB activation by decoy oligonucleotide released from PLGA microspheres.
Topics: Animals; Cell Line; Delayed-Action Preparations; Electrophoretic Mobility Shift Assay; Enzyme Activation; Enzyme Inhibitors; Gene Expression; Gene Transfer Techniques; Lactic Acid; Lipopolysaccharides; Macrophages, Peritoneal; Mice; Microscopy, Electron, Scanning; Microspheres; Mutation; NF-kappa B; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrites; Oligonucleotides; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Time Factors; Tumor Necrosis Factor-alpha | 2005 |
[Regulation of tissue factor expression in brain microvascular endothelial cells by PLA nanoparticles coating NF-kappaB decoy oligonucleotides].
Topics: Animals; Brain; Capillaries; Cells, Cultured; Endothelial Cells; Gene Expression Regulation; Lactic Acid; Nanoparticles; NF-kappa B; Oligonucleotides; Polyesters; Polymers; Rats; Thromboplastin; Transfection | 2005 |
TIDES 2006--IBC conference. Oligonucleotide and peptide technology and product development. 1-3 May 2006, Carlsbad, CA, USA.
Topics: Antiviral Agents; California; Drug Delivery Systems; Drug Design; Humans; Lactic Acid; Liposomes; Microspheres; Oligonucleotides; Peptides; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Retinal Diseases; RNA, Small Interfering; Toll-Like Receptor 9; Transforming Growth Factor beta; Transforming Growth Factor beta2 | 2006 |
Microparticle-based delivery of oxytocin receptor antisense DNA in the medial amygdala blocks social recognition in female mice.
Topics: Amygdala; Animals; Behavior, Animal; Female; Lactic Acid; Male; Mice; Microspheres; Molecular Weight; Oligonucleotides; Oligonucleotides, Antisense; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rats; Receptors, Oxytocin; Risk Assessment; Sexual Behavior, Animal | 2007 |
TLR ligands and antigen need to be coencapsulated into the same biodegradable microsphere for the generation of potent cytotoxic T lymphocyte responses.
Topics: Adjuvants, Immunologic; Animals; Antigens; Bone Marrow Cells; CD8-Positive T-Lymphocytes; Cell Survival; CpG Islands; Cytokines; Dendritic Cells; Drug Compounding; Excipients; Flow Cytometry; Immunity, Cellular; Interferon Inducers; Lactic Acid; Ligands; Mice; Mice, Inbred C57BL; Microspheres; Myosin Heavy Chains; Oligonucleotides; Poly I-C; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; T-Lymphocytes, Cytotoxic; Toll-Like Receptors | 2008 |
Nanoparticles deliver triplex-forming PNAs for site-specific genomic recombination in CD34+ human hematopoietic progenitors.
Topics: Antigens, CD34; beta-Globins; Cell Survival; Cells, Cultured; DNA; Gene Targeting; Gene Transfer Techniques; Genome; Hematopoietic Stem Cells; Humans; Lactic Acid; Nanoparticles; Oligonucleotides; Particle Size; Peptide Nucleic Acids; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Receptors, CCR5; Recombination, Genetic; Targeted Gene Repair | 2011 |
Oral nuclear factor-κB decoy oligonucleotides delivery system with chitosan modified poly(D,L-lactide-co-glycolide) nanospheres for inflammatory bowel disease.
Topics: Animals; Chitosan; Drug Carriers; Inflammatory Bowel Diseases; Lactic Acid; Male; Nanospheres; NF-kappa B; Oligonucleotides; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Wistar | 2011 |
Ghrelin neutralization during fasting-refeeding cycle impairs the recuperation of body weight and alters hepatic energy metabolism.
Topics: Animals; Blood Glucose; Carnitine O-Palmitoyltransferase; Eating; Energy Metabolism; Food Deprivation; Ghrelin; Glucokinase; Glucose; Glycogen; Growth Hormone; Hexokinase; Insulin; Lactic Acid; Lipogenesis; Liver; Male; Oligonucleotides; Pyruvate Kinase; Rats; Rats, Wistar; Transcription, Genetic; Triglycerides; Weight Gain | 2011 |
Cell patterning on polylactic acid through surface-tethered oligonucleotides.
Topics: Animals; Cattle; Cell Adhesion; Cytoskeleton; DNA, Single-Stranded; HEK293 Cells; Humans; Lactic Acid; Oligonucleotides; Phospholipids; Polyesters; Polyethylene Glycols; Polymers; Tissue Scaffolds | 2015 |
Arsenite-induced pseudo-hypoxia results in loss of anchorage-dependent growth in BEAS-2B pulmonary epithelial cells.
Topics: Alveolar Epithelial Cells; Analysis of Variance; Arsenites; Cell Hypoxia; Cell Line; Energy Metabolism; Fluorescent Antibody Technique; Gas Chromatography-Mass Spectrometry; Glycolysis; Half-Life; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immunoblotting; Lactic Acid; Metabolomics; Oligonucleotides; Real-Time Polymerase Chain Reaction | 2014 |
A novel type of self-assembled nanoparticles as targeted gene carriers: an application for plasmid DNA and antimicroRNA oligonucleotide delivery.
Topics: Apoptosis; Blotting, Western; Cell Cycle; DNA; Drug Carriers; Gene Transfer Techniques; Genetic Therapy; Hep G2 Cells; Humans; Lactic Acid; MicroRNAs; Nanoparticles; Oligonucleotides; Particle Size; Plasmids; Polyethyleneimine; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Transfection; Tumor Cells, Cultured | 2016 |
Large Porous Particles for Sustained Release of a Decoy Oligonucelotide and Poly(ethylenimine): Potential for Combined Therapy of Chronic Pseudomonas aeruginosa Lung Infections.
Topics: Animals; Chronic Disease; Drug Carriers; Humans; Lactic Acid; Male; Oligonucleotides; Polyethyleneimine; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Porosity; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Rats, Wistar; Respiratory Tract Infections | 2016 |
Aptamer-modified PLGA nanoparticle delivery of triplex forming oligonucleotide for targeted prostate cancer therapy.
Topics: Animals; Aptamers, Nucleotide; Cell Line, Tumor; Humans; Lactic Acid; Male; Mice; Nanoparticles; Nanotechnology; Oligonucleotides; Polyesters; Polyethylene Glycols; Prostatic Neoplasms | 2016 |
Metabolic engineering of CHO cells for the development of a robust protein production platform.
Topics: Animals; Antibodies, Monoclonal; Bioreactors; Carbon; CHO Cells; Citric Acid Cycle; Cricetinae; Cricetulus; Cytoplasm; Cytosol; Energy Metabolism; Gene Dosage; Glucose; Glutamine; Glycosylation; Lactates; Lactic Acid; Metabolic Engineering; Mitochondria; Oligonucleotides; Oxidation-Reduction; Polysaccharides; Pyruvate Carboxylase; Pyruvic Acid; Saccharomyces cerevisiae | 2017 |